Related references
Note: Only part of the references are listed.Novel approaches to P2Y(12) inhibition and aspirin dosing
William A. E. Parker et al.
PLATELETS (2021)
Ten-year cardiovascular risk in diabetes patients without obstructive coronary artery disease: a retrospective Western Denmark cohort study
Kevin Kris Warnakula Olesen et al.
CARDIOVASCULAR DIABETOLOGY (2021)
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease
W. S. Jones et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study
Deshan Yuan et al.
CARDIOVASCULAR DIABETOLOGY (2021)
Aspirin dosing for atherosclerotic cardiovascular disease: should we be more ADAPTABLE? COMMENT
William A. E. Parker et al.
CARDIOVASCULAR RESEARCH (2021)
Antithrombotic therapy for patients with chronic coronary syndromes
William A. E. Parker et al.
HEART (2021)
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)
Juhani Knuuti et al.
EUROPEAN HEART JOURNAL (2020)
Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels
William A. E. Parker et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes: A PLATO Sub-Study
Wael Sumaya et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Glycemic Variability Is a Powerful Independent Predictive Factor of Midterm Major Adverse Cardiac Events in Patients With Diabetes With Acute Coronary Syndrome
Edouard Gerbaud et al.
DIABETES CARE (2019)
Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome
William A. E. Parker et al.
PLATELETS (2019)
Aspirin has potential benefits for primary prevention of cardiovascular outcomes in diabetes: updated literature-based and individual participant data meta-analyses of randomized controlled trials
Samuel Seidu et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Ticagrelor in Patients with Stable Coronary Disease and Diabetes
P. Gabriel Steg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Antiplatelet effect of aspirin during 24 h in patients with type 2 diabetes without cardiovascular disease
Liv Vernstrom et al.
THROMBOSIS RESEARCH (2018)
Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus
Louise Bowman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis
Carlo Patrono et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
J. W. Eikelboom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk
Katherine Kearney et al.
CARDIOVASCULAR DIABETOLOGY (2017)
Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS-TIMI 54
Deepak L. Bhatt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel Results from a prospective, randomised, double-blind, placebo-controlled study
Francesco Franchi et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Type 1 Diabetes Mellitus and Cardiovascular Disease: A Scientific Statement From the American Heart Association and American Diabetes Association
Sarah D. de Ferranti et al.
DIABETES CARE (2014)
Hypofibrinolysis in type 2 diabetes: the role of the inflammatory pathway and complement C3
Katharina Hess et al.
DIABETOLOGIA (2014)
Diabetes is associated with posttranslational modifications in plasminogen resulting in reduced plasmin generation and enzyme-specific activity
Ramzi A. Ajjan et al.
BLOOD (2013)
Fibrin Clot Structure and Platelet Aggregation in Patients with Aspirin Treatment Failure
Sos Neergaard-Petersen et al.
PLOS ONE (2013)
High-Dose Aspirin Is Required to Influence Plasma Fibrin Network Structure in Patients With Type 1 Diabetes
Sara Tehrani et al.
DIABETES CARE (2012)
A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3
K. Hess et al.
DIABETOLOGIA (2012)
Cyclooxygenase-1, not cyclooxygenase-2, is responsible for physiological production of prostacyclin in the cardiovascular system
Nicholas S. Kirkby et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications
Galia Spectre et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Effects of Aspirin on Clot Structure and Fibrinolysis Using a Novel In Vitro Cellular System
R. A. Ajjan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Aspirin resistance and diabetes mellitus
R. Ajjan et al.
DIABETOLOGIA (2008)
Heritability of clot formation, morphology, and lysis - The EuroCLOT study
Angela M. Carter et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Inhibition of platelet aggregation by AZD6140, A reversible oral P2Y12 receptor antagonist, compared with clopidogral in patients with acute coronary syndrome
Robert F. Storey et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events - A systematic review and meta-analysis
Jaapjan D. Snoep et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Raised plasma fibrinogen concentration in patients with abdominal aortic aneurysm
Hamad S. Al-Barjas et al.
ANGIOLOGY (2006)
Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin
C Watala et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
Share Paper
